The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Bilirubin Blood Test-Global Market Insights and Sales Trends 2025
Synopsis
Bilirubin is a vital compound which possesses the capability of breaking down heme, an iron-containing compound. The abnormally high level of bilirubin signifies the presence of jaundice, anemia, and other liver diseases. The bilirubin blood tests can detect elevated levels of bilirubin in the blood and assist patient in taking appropriate measures.
The global Bilirubin Blood Test market size is expected to reach US$ 1435.6 million by 2029, growing at a CAGR of 4.4% from 2023 to 2029. The market is mainly driven by the significant applications of Bilirubin Blood Test in various end use industries. The expanding demands from the Hospital, Clinic and Other, are propelling Bilirubin Blood Test market. Transcutaneous, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Bench-top segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bilirubin Blood Test, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bilirubin Blood Test market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bilirubin Blood Test market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bilirubin Blood Test sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bilirubin Blood Test covered in this report include Company, Philips, Drager, Konica Minolta, Natus Medical, Apel, Reichert Technologies, Mennen Medical and Advanced Instruments, etc.
The global Bilirubin Blood Test market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Company
Philips
Drager
Konica Minolta
Natus Medical
Apel
Reichert Technologies
Mennen Medical
Advanced Instruments
GINEVRI
Lowenstein
AVI Healthcare
Qili Medical
Beijing M&B
DAS
Kejian Hi-tech
Micro Lab
Olidef
Dison
Global Bilirubin Blood Test market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bilirubin Blood Test market, Segment by Type:
Transcutaneous
Bench-top
Global Bilirubin Blood Test market, by Application
Hospital
Clinic
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Bilirubin Blood Test companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Bilirubin is a vital compound which possesses the capability of breaking down heme, an iron-containing compound. The abnormally high level of bilirubin signifies the presence of jaundice, anemia, and other liver diseases. The bilirubin blood tests can detect elevated levels of bilirubin in the blood and assist patient in taking appropriate measures.
The global Bilirubin Blood Test market size is expected to reach US$ 1435.6 million by 2029, growing at a CAGR of 4.4% from 2023 to 2029. The market is mainly driven by the significant applications of Bilirubin Blood Test in various end use industries. The expanding demands from the Hospital, Clinic and Other, are propelling Bilirubin Blood Test market. Transcutaneous, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Bench-top segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bilirubin Blood Test, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bilirubin Blood Test market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bilirubin Blood Test market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bilirubin Blood Test sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bilirubin Blood Test covered in this report include Company, Philips, Drager, Konica Minolta, Natus Medical, Apel, Reichert Technologies, Mennen Medical and Advanced Instruments, etc.
The global Bilirubin Blood Test market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Company
Philips
Drager
Konica Minolta
Natus Medical
Apel
Reichert Technologies
Mennen Medical
Advanced Instruments
GINEVRI
Lowenstein
AVI Healthcare
Qili Medical
Beijing M&B
DAS
Kejian Hi-tech
Micro Lab
Olidef
Dison
Global Bilirubin Blood Test market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bilirubin Blood Test market, Segment by Type:
Transcutaneous
Bench-top
Global Bilirubin Blood Test market, by Application
Hospital
Clinic
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Bilirubin Blood Test companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Bilirubin Blood Test
1.1 Bilirubin Blood Test Market Overview
1.1.1 Bilirubin Blood Test Product Scope
1.1.2 Bilirubin Blood Test Market Status and Outlook
1.2 Global Bilirubin Blood Test Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Bilirubin Blood Test Market Size by Region (2018-2029)
1.4 Global Bilirubin Blood Test Historic Market Size by Region (2018-2023)
1.5 Global Bilirubin Blood Test Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Bilirubin Blood Test Market Size (2018-2029)
1.6.1 North America Bilirubin Blood Test Market Size (2018-2029)
1.6.2 Europe Bilirubin Blood Test Market Size (2018-2029)
1.6.3 Asia-Pacific Bilirubin Blood Test Market Size (2018-2029)
1.6.4 Latin America Bilirubin Blood Test Market Size (2018-2029)
1.6.5 Middle East & Africa Bilirubin Blood Test Market Size (2018-2029)
2 Bilirubin Blood Test Market by Type
2.1 Introduction
2.1.1 Transcutaneous
2.1.2 Bench-top
2.2 Global Bilirubin Blood Test Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Bilirubin Blood Test Historic Market Size by Type (2018-2023)
2.2.2 Global Bilirubin Blood Test Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Bilirubin Blood Test Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Bilirubin Blood Test Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Bilirubin Blood Test Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Bilirubin Blood Test Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Bilirubin Blood Test Revenue Breakdown by Type (2018-2029)
3 Bilirubin Blood Test Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Other
3.2 Global Bilirubin Blood Test Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Bilirubin Blood Test Historic Market Size by Application (2018-2023)
3.2.2 Global Bilirubin Blood Test Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Bilirubin Blood Test Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Bilirubin Blood Test Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Bilirubin Blood Test Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Bilirubin Blood Test Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Bilirubin Blood Test Revenue Breakdown by Application (2018-2029)
4 Bilirubin Blood Test Competition Analysis by Players
4.1 Global Bilirubin Blood Test Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bilirubin Blood Test as of 2022)
4.3 Date of Key Players Enter into Bilirubin Blood Test Market
4.4 Global Top Players Bilirubin Blood Test Headquarters and Area Served
4.5 Key Players Bilirubin Blood Test Product Solution and Service
4.6 Competitive Status
4.6.1 Bilirubin Blood Test Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Company
5.1.1 Company Profile
5.1.2 Company Main Business
5.1.3 Company Bilirubin Blood Test Products, Services and Solutions
5.1.4 Company Bilirubin Blood Test Revenue (US$ Million) & (2018-2023)
5.1.5 Company Recent Developments
5.2 Philips
5.2.1 Philips Profile
5.2.2 Philips Main Business
5.2.3 Philips Bilirubin Blood Test Products, Services and Solutions
5.2.4 Philips Bilirubin Blood Test Revenue (US$ Million) & (2018-2023)
5.2.5 Philips Recent Developments
5.3 Drager
5.3.1 Drager Profile
5.3.2 Drager Main Business
5.3.3 Drager Bilirubin Blood Test Products, Services and Solutions
5.3.4 Drager Bilirubin Blood Test Revenue (US$ Million) & (2018-2023)
5.3.5 Konica Minolta Recent Developments
5.4 Konica Minolta
5.4.1 Konica Minolta Profile
5.4.2 Konica Minolta Main Business
5.4.3 Konica Minolta Bilirubin Blood Test Products, Services and Solutions
5.4.4 Konica Minolta Bilirubin Blood Test Revenue (US$ Million) & (2018-2023)
5.4.5 Konica Minolta Recent Developments
5.5 Natus Medical
5.5.1 Natus Medical Profile
5.5.2 Natus Medical Main Business
5.5.3 Natus Medical Bilirubin Blood Test Products, Services and Solutions
5.5.4 Natus Medical Bilirubin Blood Test Revenue (US$ Million) & (2018-2023)
5.5.5 Natus Medical Recent Developments
5.6 Apel
5.6.1 Apel Profile
5.6.2 Apel Main Business
5.6.3 Apel Bilirubin Blood Test Products, Services and Solutions
5.6.4 Apel Bilirubin Blood Test Revenue (US$ Million) & (2018-2023)
5.6.5 Apel Recent Developments
5.7 Reichert Technologies
5.7.1 Reichert Technologies Profile
5.7.2 Reichert Technologies Main Business
5.7.3 Reichert Technologies Bilirubin Blood Test Products, Services and Solutions
5.7.4 Reichert Technologies Bilirubin Blood Test Revenue (US$ Million) & (2018-2023)
5.7.5 Reichert Technologies Recent Developments
5.8 Mennen Medical
5.8.1 Mennen Medical Profile
5.8.2 Mennen Medical Main Business
5.8.3 Mennen Medical Bilirubin Blood Test Products, Services and Solutions
5.8.4 Mennen Medical Bilirubin Blood Test Revenue (US$ Million) & (2018-2023)
5.8.5 Mennen Medical Recent Developments
5.9 Advanced Instruments
5.9.1 Advanced Instruments Profile
5.9.2 Advanced Instruments Main Business
5.9.3 Advanced Instruments Bilirubin Blood Test Products, Services and Solutions
5.9.4 Advanced Instruments Bilirubin Blood Test Revenue (US$ Million) & (2018-2023)
5.9.5 Advanced Instruments Recent Developments
5.10 GINEVRI
5.10.1 GINEVRI Profile
5.10.2 GINEVRI Main Business
5.10.3 GINEVRI Bilirubin Blood Test Products, Services and Solutions
5.10.4 GINEVRI Bilirubin Blood Test Revenue (US$ Million) & (2018-2023)
5.10.5 GINEVRI Recent Developments
5.11 Lowenstein
5.11.1 Lowenstein Profile
5.11.2 Lowenstein Main Business
5.11.3 Lowenstein Bilirubin Blood Test Products, Services and Solutions
5.11.4 Lowenstein Bilirubin Blood Test Revenue (US$ Million) & (2018-2023)
5.11.5 Lowenstein Recent Developments
5.12 AVI Healthcare
5.12.1 AVI Healthcare Profile
5.12.2 AVI Healthcare Main Business
5.12.3 AVI Healthcare Bilirubin Blood Test Products, Services and Solutions
5.12.4 AVI Healthcare Bilirubin Blood Test Revenue (US$ Million) & (2018-2023)
5.12.5 AVI Healthcare Recent Developments
5.13 Qili Medical
5.13.1 Qili Medical Profile
5.13.2 Qili Medical Main Business
5.13.3 Qili Medical Bilirubin Blood Test Products, Services and Solutions
5.13.4 Qili Medical Bilirubin Blood Test Revenue (US$ Million) & (2018-2023)
5.13.5 Qili Medical Recent Developments
5.14 Beijing M&B
5.14.1 Beijing M&B Profile
5.14.2 Beijing M&B Main Business
5.14.3 Beijing M&B Bilirubin Blood Test Products, Services and Solutions
5.14.4 Beijing M&B Bilirubin Blood Test Revenue (US$ Million) & (2018-2023)
5.14.5 Beijing M&B Recent Developments
5.15 DAS
5.15.1 DAS Profile
5.15.2 DAS Main Business
5.15.3 DAS Bilirubin Blood Test Products, Services and Solutions
5.15.4 DAS Bilirubin Blood Test Revenue (US$ Million) & (2018-2023)
5.15.5 DAS Recent Developments
5.16 Kejian Hi-tech
5.16.1 Kejian Hi-tech Profile
5.16.2 Kejian Hi-tech Main Business
5.16.3 Kejian Hi-tech Bilirubin Blood Test Products, Services and Solutions
5.16.4 Kejian Hi-tech Bilirubin Blood Test Revenue (US$ Million) & (2018-2023)
5.16.5 Kejian Hi-tech Recent Developments
5.17 Micro Lab
5.17.1 Micro Lab Profile
5.17.2 Micro Lab Main Business
5.17.3 Micro Lab Bilirubin Blood Test Products, Services and Solutions
5.17.4 Micro Lab Bilirubin Blood Test Revenue (US$ Million) & (2018-2023)
5.17.5 Micro Lab Recent Developments
5.18 Olidef
5.18.1 Olidef Profile
5.18.2 Olidef Main Business
5.18.3 Olidef Bilirubin Blood Test Products, Services and Solutions
5.18.4 Olidef Bilirubin Blood Test Revenue (US$ Million) & (2018-2023)
5.18.5 Olidef Recent Developments
5.19 Dison
5.19.1 Dison Profile
5.19.2 Dison Main Business
5.19.3 Dison Bilirubin Blood Test Products, Services and Solutions
5.19.4 Dison Bilirubin Blood Test Revenue (US$ Million) & (2018-2023)
5.19.5 Dison Recent Developments
6 North America
6.1 North America Bilirubin Blood Test Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Bilirubin Blood Test Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Bilirubin Blood Test Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Bilirubin Blood Test Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Bilirubin Blood Test Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Bilirubin Blood Test Market Dynamics
11.1 Bilirubin Blood Test Industry Trends
11.2 Bilirubin Blood Test Market Drivers
11.3 Bilirubin Blood Test Market Challenges
11.4 Bilirubin Blood Test Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
